Pediatrix Medical Group, Inc.
MD Healthcare Medical Care Facilities
Pediatrix Medical Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, down 4.92% from fiscal 2024.
- Revenue
- +1.72%
- EPS
- −27.6%
- Free cash flow
- −14.4%
- Total debt
- −4.11%
Quarter to September 2026, against a year earlier
Follow MD
Alert me
Pediatrix Medical Group, Inc. (MD) EV/EBITDA
As of 5 November 2026, Pediatrix Medical Group, Inc. (MD) trades at a EV/EBITDA of 11.0×. Over the past ten years it has ranged from 0.0× (June 2025) to 44.1× (April 2024); the current reading is higher than 42% of that period. That is below the Medical Care Facilities industry median of 11.9× and above the Healthcare sector median of 8.4×.
EV/EBITDA, daily
Embed this chart
Annual newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| FY2025 | 8.2× | — |
| FY2024 | 0.0× | — |
| FY2023 | 27.4× | 219.73% |
| FY2022 | 8.6× | (27.34%) |
| FY2021 | 11.8× | (39.38%) |
| FY2020 | 19.5× | 29.37% |
| FY2019 | 15.1× | (15.06%) |
| FY2018 | 17.7× | 39.65% |
| FY2017 | 12.7× | 7.91% |
| FY2016 | 11.8× | (6.99%) |
Quarterly newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| Sep 2026 | 9.0× | (1.42%) |
| Jun 2026 | 9.2× | 11.28% |
| Mar 2026 | 8.2× | 0.61% |
| Dec 2025 | 8.2× | 17.47% |
| 43 more quarters | Free account |
Against its own ten years
EV/EBITDA against peers
| Company | EV/EBITDA |
|---|---|
| ACHC Acadia Healthcare Company, Inc. compare | 9.9× |
| MD Pediatrix Medical Group, Inc. | 11.0× |
| SGRY Surgery Partners, Inc. compare | 11.2× |
| ADUS Addus HomeCare Corporation compare | 13.0× |
| AVAH Aveanna Healthcare Holdings Inc. compare | 14.1× |
| ASTH Astrana Health, Inc. compare | 14.5× |
| BKD Brookdale Senior Living Inc. compare | 14.9× |
| NHC National HealthCare Corporation compare | 16.1× |
| GRDN Guardian Pharmacy Services, Inc. compare | 20.7× |
| Medical Care Facilities industry median | 11.9× |
| Healthcare sector median | 8.4× |
| Market median | 10.9× |
What EV/EBITDA is
Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)
More on MD
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement